The Journal of Urology
Volume 182, Issue 6 , Pages 2565-2566 , December 2009

Active Surveillance for Favorable Risk Prostate Cancer

References 

  1. Welch HG, Schwartz LM, Woloshin S. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal. J Natl Cancer Inst. 2005;97:1132
  2. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J Natl Cancer Inst. 2009;Epub ahead of print
  3. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320
  4. Bill-Axelson A, Holmberg L. Radical prostatectomy versus watchful waiting. (update) N Engl J Med. 2005;352:1977
  5. Klotz LH, Nam R, Lam A, et al. Clinical results of long-term follow-up of a large active surveillance cohort. J Urol. 2009;181(suppl.):606;abstract 1682

PII: S0022-5347(09)02520-8

doi: 10.1016/j.juro.2009.09.038

The Journal of Urology
Volume 182, Issue 6 , Pages 2565-2566 , December 2009

Article Tools